Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
Cash Flows From Operating Activities | |||||
Net Income | -21,310 | -36,732 | -39,615 | -27,978 | -40,531 |
Depreciation Amortization | 5,328 | 5,772 | 4,402 | 4,784 | 5,238 |
Accounts receivable | 173 | -44 | -129 | 10,000 | -10,000 |
Accounts payable and accrued liabilities | -1,357 | -1,990 | 1,642 | -1,456 | 822 |
Other Working Capital | -733 | -2,825 | -5,868 | 2,267 | -5,539 |
Other Operating Activity | -13,984 | -5,680 | 38,956 | -5,858 | 15,584 |
Operating Cash Flow | $-31,883 | $-41,499 | $-612 | $-18,241 | $-34,426 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 19,496 | -11,163 | -8,577 | 2,000 | 25,571 |
PPE Investments | -43 | -2,363 | -1,768 | -27 | -496 |
Investing Cash Flow | $19,453 | $-13,526 | $-10,345 | $1,973 | $25,075 |
Cash Flows From Financing Activities | |||||
Debt Issued | 2,914 | 50,830 | 15,000 | 0 | 0 |
Debt Repayment | 0 | -781 | -5,773 | -6,110 | -5,563 |
Common Stock Issued | 182 | 5,878 | 6,583 | 35,242 | 16,145 |
Other Financing Activity | 1,889 | -3,008 | -5,262 | -10,051 | 0 |
Financing Cash Flow | $4,985 | $52,919 | $10,548 | $19,081 | $10,582 |
Beginning Cash Position | 15,200 | 17,306 | 17,715 | 14,902 | 13,671 |
End Cash Position | 7,755 | 15,200 | 17,306 | 17,715 | 14,902 |
Net Cash Flow | $-7,445 | $-2,106 | $-409 | $2,813 | $1,231 |
Free Cash Flow | |||||
Operating Cash Flow | -31,883 | -41,499 | -612 | -18,241 | -34,426 |
Capital Expenditure | -58 | -2,363 | -1,784 | -452 | -496 |
Free Cash Flow | -31,941 | -43,862 | -2,396 | -18,693 | -34,922 |